Bioxytran, Inc financial data

Symbol
BIXT on OTC
Location
C/O Bioxytran, Inc., 75 2 Nd Ave, Suite 605 Ste 605, Needham, MA
State of incorporation
NV
Fiscal year end
December 31
Former names
U.S. RARE EARTH MINERALS, INC. (to 10/30/2018), U.S. RARE EARTH MINERALS, INC (to 10/3/2018), U.S. Natural Nutrients & Minerals, Inc. (to 4/14/2011), AMERICA'S DRIVING RANGES, INC. (to 10/29/2009)
Latest financial report
10-K - Q4 2024 - Apr 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.15 % -52.6%
Return On Equity 191 % +27.5%
Return On Assets -1.72K % +32.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 88.9M shares -46.6%
Common Stock, Shares, Outstanding 86.8M shares -40%
Entity Public Float 8M USD -13%
Common Stock, Value, Issued 86.8K USD -40%
Weighted Average Number of Shares Outstanding, Basic 139M shares +3.45%
Weighted Average Number of Shares Outstanding, Diluted 139M shares +3.45%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 51K USD -83.9%
General and Administrative Expense 1.17M USD -16.8%
Operating Income (Loss) -2.22M USD +41.5%
Nonoperating Income (Expense) -387K USD +13.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.38M USD +47.8%
Net Income (Loss) Attributable to Parent -2.37M USD +47.1%
Earnings Per Share, Basic -0.02 USD/shares +33.3%
Earnings Per Share, Diluted -0.02 USD/shares +33.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current 5.15K USD -80.2%
Assets 139K USD -0.49%
Accounts Payable, Current 201K USD
Liabilities, Current 1.93M USD -40.5%
Liabilities 1.93M USD -40.5%
Retained Earnings (Accumulated Deficit) -18.9M USD -20.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -1.79M USD +42.3%
Liabilities and Equity 139K USD -0.49%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -75.6K USD +59.6%
Net Cash Provided by (Used in) Financing Activities 65.5K USD +31%
Net Cash Provided by (Used in) Investing Activities -6K USD -27.3%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 86.8M shares -40%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Interest Paid, Excluding Capitalized Interest, Operating Activities 52.4K USD
Deferred Tax Assets, Valuation Allowance 3.28M USD +19.3%
Deferred Tax Assets, Gross 3.28M USD +19.3%
Deferred Tax Assets, Operating Loss Carryforwards 15.6M USD +19.3%
Preferred Stock, Shares Issued 43.2M shares
Preferred Stock, Shares Authorized 50M shares 0%
Additional Paid in Capital 17M USD +29.9%
Preferred Stock, Shares Outstanding 43.2M shares
Amortization of Intangible Assets 7.95K USD -4.04%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%